Invesco Dynamic Biotechnology & Genome ETF
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| Q1 2013 | 142.66K | 16.36M | 11468.44% |
|---|---|---|---|
| Q2 2013 | 171.36K | 19.98M | 11662.06% |
| Q3 2013 | 171.36K | 19.98M | 11662.06% |
PBE Income Statement (Q1 2013 – Q3 2013)
| Q3 2013 | Q2 2013 | Q1 2013 | |
|---|---|---|---|
Revenue | |||
Revenue | 171.36K | 171.36K | 142.66K |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 171.36K | 171.36K | 142.66K |
Operating exp. | |||
Research and development | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 19.81M | 19.81M | 16.21M |
Operating income | -111.43K | -111.43K | -73.77K |
Other income (expenses), net | 20.09M | 20.09M | 16.43M |
Income before tax | 19.98M | 19.98M | 16.36M |
Income tax expense | 20.09M | 20.09M | 16.43M |
Net income | 19.98M | 19.98M | 16.36M |
Earnings per share | |||
Basic EPS | 2.68 | 2.68 | 2.97 |
Diluted EPS | 2.68 | 2.68 | 2.97 |